• Vaxil Locations
  • Contact Us
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media

2018 Public Filings Now Available

Posted on February 2, 2019April 30, 2020 by David Goren
02 Feb

 

2018 financial statement and MD&A now available on the “Public Filings” section of the Vaxil website along with other public filings.

 

Attached:

2018 Financial Statements
2018 Management Discussion and Analysis

This entry was posted in Annnouncements. Bookmark the permalink.
Vaxil Appoints Veteran Pharma Executive David Goren as CEO
Q1 2019 Financials Now Available

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, Weizmann Science Park, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Presentations
  • Public Filings
  • News and Updates
  • In the Media
  • Video
  • Scientific Publications
Copyright 2024 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • Vaxil Locations
  • Contact Us
  • Subscribe